MU Logo Department of Internal Medicine at MUMu Health Care

Cardiovascular Medicine Faculty

Anand Chockalingam, M.D., F.A.C.C., F.A.H.A.

Assistant Professor of Clinical Medicine

Dr. Chockalingam’s primary areas of interest are valvular disease, heart failure and echocardiography.

Board Certification :

  • Internal Medicine
  • Echocardiography
  • Nuclear Cardiology

 

Anand Chockalingam

Medical School

Madras Medical College & Research Institute
Chennai, India


Residency

Western Pennsylvania Hospital/Temple University
Pittsburgh, Pennsylvania


Fellowship: Cardiovascular Disease

Madras Medical College & Research Institute
Chennai, India

Honors and Organizations:

  • Fellow, American College of Cardiology,
  • Fellow, American Heart Association & Council of Clinical Cardiology
  • American Society of Echocardiography
  • Reviewer for Circulation, American Heart Journal, Angiology, International Journal of Cardiology

Recent Publications

  • Chockalingam A, Gnanavelu G, Venkatesan S, Elangovan S, Jagannathan V, Subramaniam T, Alagesan R, Dorairajan S. Efficacy And Optimal Dose Of Sildenafil In Primary Pulmonary Hypertension. Int J Cardiol. 2005;99:91-95.

  • Chockalingam A, Venkatesan S, Dorairajan S, Chockalingam V, Subramaniam T, Jaganathan V, Elangovan S, Alagesan R, Gnanavelu G, Arul AS. Safety and Efficacy of Enalapril in Multivalvular Heart Disease with Significant Mitral Stenosis: SCOPE-MS. Angiology. 2005;56:151-8

  • Chockalingam A, Dass SH, Alagesan R, Muthukumar D, Subramaniam T, Jaganathan V, Elangovan S. Role Of Transthoracic Doppler Pulmonary Venous Flow Pattern In Large Atrial Septal Defects. Echocardiography. 2005;22:9-13

  • Chockalingam A, Gnanavelu G, Subramaniam T, Dorairajan S, Chockalingam V. Right Ventricular Myocardial Infarction: Presentation and Acute Outcomes. Angiology. 2005;56:371-6.

  • Chockalingam A, Venkatesan S, Subramaniam T, Jagannathan V, Elangovan S, Alagesan R, Gnanavelu G, Dorairajan S, Krishna BP, Chockalingam V. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS). Am Heart J. 2004:147;740

Webmaster | ©2006 Curators of the University of Missouri DMCA and other copyright information
All rights reserved. An equal opportunity/ADA institution.
Last Revised: 01/23/2008